369 related articles for article (PubMed ID: 6278057)
61. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
[No Abstract] [Full Text] [Related]
62. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance.
Darby G; Field HJ; Salisbury SA
Nature; 1981 Jan; 289(5793):81-3. PubMed ID: 6256650
[TBL] [Abstract][Full Text] [Related]
63. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Docherty JJ; Dobson AT; Trimble JJ; Jennings BA
Intervirology; 1991; 32(5):308-15. PubMed ID: 1657822
[TBL] [Abstract][Full Text] [Related]
64. Differential binding affinities of sugar-modified derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine for herpes simplex virus-induced and human cellular deoxythymidine kinases.
Zou FC; Dutschman GE; De Clercq E; Cheng YC
Biochem Pharmacol; 1984 Jun; 33(11):1797-800. PubMed ID: 6329218
[TBL] [Abstract][Full Text] [Related]
65. Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.
Jamieson AT; Gentry GA; Subak-Sharpe JH
J Gen Virol; 1974 Sep; 24(3):465-80. PubMed ID: 4372299
[No Abstract] [Full Text] [Related]
66. Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus.
Biron KK; Fyfe JA; Noblin JE; Elion GB
Am J Med; 1982 Jul; 73(1A):383-6. PubMed ID: 6285728
[TBL] [Abstract][Full Text] [Related]
67. 5-Methoxymethyldeoxyuridine-resistant mutants of herpes simplex virus type 1.
Veerisetty V; Gentry GA
Virology; 1981 Oct; 114(2):576-9. PubMed ID: 6270889
[No Abstract] [Full Text] [Related]
68. Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus. Evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase.
Larder BA; Derse D; Cheng YC; Darby G
J Biol Chem; 1983 Feb; 258(3):2027-33. PubMed ID: 6296119
[TBL] [Abstract][Full Text] [Related]
69. Activity and mechanism of action of HDVD, a novel pyrimidine nucleoside derivative with high levels of selectivity and potency against gammaherpesviruses.
Coen N; Singh U; Vuyyuru V; Van den Oord JJ; Balzarini J; Duraffour S; Snoeck R; Cheng YC; Chu CK; Andrei G
J Virol; 2013 Apr; 87(7):3839-51. PubMed ID: 23345517
[TBL] [Abstract][Full Text] [Related]
70. Problems associated with the use of (E)-5-(2-bromovinyl)-2'-deoxyuridine for typing herpes simplex virus.
Swierkosz EM; Arens MQ; Rivetna KA
J Clin Microbiol; 1985 Mar; 21(3):459-61. PubMed ID: 2984249
[TBL] [Abstract][Full Text] [Related]
71. Herpesvirus proteins: induction of nucleoside phosphotransferase activity after herpes simplex virus infection.
Jamieson AT; Hay J; Subak-Sharpe JH
J Virol; 1976 Mar; 17(3):1056-9. PubMed ID: 176440
[TBL] [Abstract][Full Text] [Related]
72. Analysis of deoxycytidine (dC) deaminase activity in herpes simplex virus-infected or HSV TK-transformed cells: association with mycoplasma contamination but not with virus infection.
Charron J; Langelier Y
J Gen Virol; 1981 Nov; 57(Pt 1):245-50. PubMed ID: 6275019
[TBL] [Abstract][Full Text] [Related]
73. Thymidine kinase not required for antiviral activity of acyclovir against mouse cytomegalovirus.
Burns WH; Wingard JR; Bender WJ; Saral R
J Virol; 1981 Sep; 39(3):889-93. PubMed ID: 6270357
[TBL] [Abstract][Full Text] [Related]
74. Proteins of herpesvirus saimiri: identification of two virus polypeptides released into the culture medium of productively infected cells.
Randall RE; Honess RW
J Gen Virol; 1980 Dec; 51(Pt 2):445-9. PubMed ID: 6262446
[TBL] [Abstract][Full Text] [Related]
75. Kinetic studies with N2-phenylguanines and with L-thymidine indicate that herpes simplex virus type-1 thymidine kinase and thymidylate kinase share a common active site.
Maga G; Focher F; Wright GE; Capobianco M; Garbesi A; Bendiscioli A; Spadari S
Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):279-82. PubMed ID: 8068016
[TBL] [Abstract][Full Text] [Related]
76. A single major immediate-early virus gene product is synthesized in cells productively infected with herpesvirus saimiri.
Randall RE; Newman C; Honess RW
J Gen Virol; 1984 Jul; 65 ( Pt 7)():1215-9. PubMed ID: 6086813
[TBL] [Abstract][Full Text] [Related]
77. Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells.
Stenberg K; Larsson A; Datema R
J Biol Chem; 1986 Feb; 261(5):2134-9. PubMed ID: 2418021
[TBL] [Abstract][Full Text] [Related]
78. Interaction of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) with owl monkey kidney cells in enhancing the yields of Herpesvirus saimiri (HVS) and its antigens.
Faggioni A; Ablashi DV; Dahlberg J; Armstrong G; Sundar SK
Proc Soc Exp Biol Med; 1984 Sep; 176(4):407-13. PubMed ID: 6087360
[TBL] [Abstract][Full Text] [Related]
79. Alterations in substrate specificity and physicochemical properties of deoxythymidine kinase of a drug-resistant herpes simplex virus type 1 mutant.
Veerisetty V; Gentry GA
J Virol; 1983 Jun; 46(3):901-8. PubMed ID: 6304349
[TBL] [Abstract][Full Text] [Related]
80. Antiviral activities and phosphorylation of 5-halo-2'-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virus.
Smee DF; Humphreys DE; Hurst BL; Barnard DL
Antivir Chem Chemother; 2008; 19(1):15-24. PubMed ID: 18610554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
